Career summary: Dr. Bharadwaj is an early-mid career researcher with more than 10 years of experience in neurodegenerative diseases. He currently leads the Childhood Dementia research at Edith Cowan University and Alzheimer's Research Australia based in WA. His work specializes in developing prognostic biomarkers for childhood dementia. Dr. Bharadwaj is an expert in autophagy-lysosomal pathway, an important cellular mechanism implicated in multiple neurodegenerative disorders, including AD and rare childhood dementias. His PhD studies established cell models for Alzheimer’s disease (AD) in collaboration with the CSIRO preventive health flagship. His PhD work led to a successful NHMRC grant, which funded his position at ECU. From 2015-2016, he was offered a position as a research associate at Curtin University. In 2016, he was awarded the NHMRC-ARC dementia research development fellowship in AD. In 2022, Dr. Bharadwaj was awarded $250,000 by the WA-Child Research Foundation (WACRF) grant to develop biomarkers for rare childhood dementia. Recently, he was awarded $250,000 (2023-25) by the National Foundation for Medical Research and Innovation (NFMRI) to study the neurodegeneration biomarker, Neurofilament light in AD and other dementias. Grants, Publications and Presentations: Dr. Bharadwaj’s research work has received more than $1 million in competitive funding in the last 5 years including the industry award from Atomwise, National Health and Medical Research Council (NHMR